ArticleMedicine international
Palliative care in patients with glioblastoma: A systematic review.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pharmacological activity, molecular mechanisms and therapeutic potential of erianin (Review).International journal of molecular medicine · 2026Review
- Post-recurrence management of malignant glial brain tumors: therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Review
- Clinical Predictors of Survival After Palliative Radiotherapy for Glioblastoma in a Real-World Cohort Study.Current oncology (Toronto, Ont.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study aimed to systematically review and analyze the available literature on patients with glioblastoma (GBM) receiving palliative care. A systemic literature review was thus conducted searching for patients with GBM receiving palliative care using the following databases: PubMed, Scopus, Wiley and Web of Science. All articles relevant to the review were included, covering all age groups and types of palliative care used in all settings, and there was no time limit. A total of 234 studies were obtained from the search that matched the objectives of the review. A total of 19 articles were included, ranging from 1998 to 2022, with a total number of 7,392 patients. Supportive treatment was one approach to palliative and end-of-life care in patients with GBM; other approaches included chemotherapy, surgery and radiotherapy. The location of the mortality of patients with GBM differed between hospitals and health institutes, homes and hospice care. Out of 19 studies included, 10 of these reported hospitals to be the place of mortality. Patients with GBM have a poor prognosis, with a poor survival rate, even with the optimal treatment available. Moreover, multiple signs and symptoms can burden the end-of-life of patients and their families. Palliative care in these patients aims to relieve the burden of end-of-life care and improve the quality of life of the patients and their families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.